We tested whether the combined nano-formulation, prepared with curcumin (anti-inflammatory and neuroprotective molecule) and embryonic stem cell exosomes (MESC-exo cur ), restored neurovascular loss following an ischemia reperfusion (IR) injury in mice. IR-injury was created in 8-10 weeks old mice and divided into two groups. Out of two IR-injured groups, one group received intranasal administration of MESC-exo cur for 7 days. Similarly, two sham groups were made and one group received MESC-exo cur treatment. The study determined MESC-exo cur reduced neurological score, infarct volume and edema following IR-injury. As compared to untreated IR group, MESC-exo cur treated-IR group showed reduced inflammation and N-methyl-D-aspartate receptor expression. Treatment of MESC-exo cur also reduced astrocytic GFAP expression and alleviated the expression of NeuN positive neurons in IR-injured mice. In addition, MESC-exo cur treatment restored vascular endothelial tight (claudin-5 and occludin) and adherent (VE-cadherin) junction proteins in IR-injured mice as compared to untreated IR-injured mice. These results suggest that combining the potentials of embryonic stem cell exosomes and curcumin can help neurovascular restoration following ischemia-reperfusion injury in mice.
Introduction
According to the recent reports, stroke is the fifth major cause of death and a leading cause of disability in adults of United States (Kochanek et al., 2014; Mozaffarian et al., 2015) . Each year about 800,000 US people experience stroke and on average, one American death was reported every 4 min (Mozaffarian et al., 2015) . After attempting decades of efforts in developing neuro-restoration therapy that could also help reducing ischemic lesion volume, yellow colored spice and possess remarkable medicinal properties. The therapeutic efficacy of curcumin has been extensively studied against ischemic stroke which is attributed by promoting free radical scavenging, anti-inflammatory, anti-lipidemic and anti-aggregation properties (Kalani et al., 2014c; Soni and Kuttan, 1992; Strimpakos and Sharma, 2008) . Extensive medicinal properties led curcumin towards clinical trials to prevent brain diseases; however, phase-I clinical trials were unsuccessful because of its low bioavailability (Anand et al., 2007; Ovbiagele, 2008; Perry and Howes, 2011) . Poor absorption, quick metabolism, and rapid systemic elimination are the factors that limit curcumin bioavailability. These problems led other ways explored by the investigators. Patra et. al. (Patra and Sleem, 2013) have developed a novel method for encapsulation of curcumin by synthesizing microcapsule containing self-assembled nanoparticles using poly (l-lysine), trisodium citrate and silica sol. Mouslmani et al (Mouslmani M, 2015) developed hierarchically ordered nanocapsule structures by crosslinking curcumin associated poly (allylamine hydrochloride) with dipotassium phosphate and subsequently congregates with silica nanoparticles (Mouslmani M, 2015) . Excitingly, curcumin loaded in exosomes was not only found more stable, highly soluble and highly concentrated in the blood but also appeared to express more therapeutic potentials (Sun et al., 2010; Zhuang et al., 2011 ). In the current report, we sought to determine the neuro-vascular restoration therapy of MESC-exo cur [curcumin loaded in MESC-exo (mouse embryonic stem cell-derived exosomes)] following an ischemia reperfusion injury in mouse model.
Methodology
All procedures were conducted in compliance with guidelines established by the National Institute of Health (NIH) Guide for the Care and Use of Laboratory Animals and were approved by the University of Louisville's Institutional Animal Care and Use Committee. 8-10 weeks old male wild-type (WT, C57BL/6J) mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). The experimental mice groups were: 1) sham, 2) sham + MESC-exo cur , 3) IR, and 4) IR+ MESC-exo cur .
Animal Surgical Procedure
Mice were anesthetized with sodium pentobarbital (50 mg/kg body wt.) and operated within 1h. Anesthetized mice were orally intubated, mechanically ventilated and the body temperature was maintained at 37 ± 1°C during surgery. A midline neck incision was made and common carotid artery (CCA) was exposed carefully. Silicon-rubber coated monofilament (diameter 0.22, 0.23 mm, size 6-0 or 7-0) was used to obstruct middle cerebral artery after inserting it into internal carotid artery and advancing to internal carotid artery. After 40 min of surgery, the filaments were withdrawn to allow reperfusion. Same anesthesia and surgical procedures were performed in sham groups of mice except the insertion of monofilament (Kalani et al., 2015) . After the surgery, mice were tested for the neurobehavioral tests to determine neurological deficit score (Belayev et al., 1996; Kalani et al., 2015) . The neurological deficit score was reported on a blind fashion using a scale 0 to 12 (normal score=0, maximum=12). Mice showing high neurological deficit scores (>10) were used in the current study.
Isolation of mouse embryonic stem cell exosomes and their characterization
Mouse embryonic stem cell line was procured from American Type Culture Collection (ATCC, Menassas, VA, USA) and grown on a fibroblast monolayer as per supplier's stepby-step protocol. The cells were maintained in 25 or 75 cm 2 tissue culture flasks under the atmosphere set at 5% CO 2 and 95% air in an incubator. For exosome collection, the cells were made 50-60% confluent and the media was changed, which was prepared with exosome free serum. After 48-72 h of culture, media was collected and processed as described in our earlier report (Kalani et al., 2014a) , with certain modifications. Briefly, culture media was centrifuged at 3,000 × g (10 min) and supernatant was re-centrifuged at 10,000 × g (15 min). 10,000 × g supernatant was collected and ultracentrifuged at 1, 40,000 × g for 3 h to concentrate MESC-exo in pellet. Characterization of exosome was performed with western blot with TSG101 antibody (Kalani et al., 2014a) , acetylcholinesterase activity (Kalani et al., 2014a) , and nano-tracking (NTA) analysis (Sokolova et al., 2011) .
Packing of curcumin in MESC-exo and intranasal delivery
The loading of curcumin (dissolved in ethanol) was achieved by mixing it to MESC-exos in a fixed proportion (1: 4). The nanopreparation was incubated for 15 min at room temperature and rapif freeze-thawing was done 2-3 times.. The unbound drug was removed by centrifuging the preparation twice at 5,000 Xg. The formulation was precipitated either by ultracentrifuging at 1, 40,000 × g for 3 h or precipitating with total exosome isolation reagent (ThermoFisher Scientific, Grand Island, NY, USA). Fresh preparations of MESCexo cur were used for intranasal delivery in two groups of mice (sham + MESC-exo cur and IR + MESC-exo cur ). Total 10 μl MESC-exo cur was administered, twice a day, by alternate nostrils (2 μl × 5 times) started within an hour of IR and sham surgery and continued till 7 days. Neurological behavior tests for instance, posture relax test, forelimb placing test and motor coordination tests were performed on 1 st , 3 rd and 7 th day post-MESC-exo cur administration.
Collection of brain samples
At the end of the experiment, mice were intracardially perfused with phosphate buffer saline (50mM PBS, pH=7.4) under deep anesthesia. Brain samples were carefully harvested after opening the cranium, washed with ice-cold PBS, and used for various experimental procedures.
Determination of Infarct Volume (IV)
2 mm size coronal sections were cut using a mouse brain slice matrix (Harvard Apparatus, Holliston, MA, USA). 2% of 2,3,5-Triphenyltetrazolium chloride (TTC; Sigma Aldrich, Taufkirchen, Germany) was used to stain the sections. After staining the sections for 20 min in TTC, sections were fixed in 4% paraformaldehyde. Infarct area (pale white color) was determined with image analysis software (Image-Pro Plus, USA).
Cerebral edema
The cortical parts of the brain ipsilateral area were dried for 3 days in drying oven at 100°C. Water content was calculated in percentage using the formula, (wet weight-dry weight)/wet weight]*100.
Measurement of reactive oxygen species (ROS)
The ROS level was determined in the experimental brains spectrometrically as determined earlier (Tota et al., 2012) . Briefly, brain tissue was minced and treated with collagenase (750 unit/ml) in HEPES-Tyrode solution (145 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 5 mM glucose, 5 mM HEPES, pH 7.4) for 40 min at 37°C. Dissociated cells were stained with oxidation sensitive fluorescent probe 5 μM DCF (2′,7′-dichlorodihydrofluorescein diacetate) for 15 min at 37°C and then washed with HEPES. The formation of the fluorescent product DCF was assessed with excitation/emission wavelengths of 488 nm/530 nm.
Measurement of Lipid Peroxidation
Malondialdehyde (MDA), one of the final products of polyunsaturated fatty acids peroxidation, was used to assess lipid peroxidation using 1,1,3,3-tetraethoxypropane as a standard. Cerebral cortex and hippocampus regions of the mice brains were homogenized and tested separately. The reaction mixture was consisted of 0.3 ml thiobarbituric acid (2 %), and 0.15 ml 5 N HCl with homogenized brain tissue samples (Kalani et al., 2014b) . The samples were shaken well and heated at 90 °C for 15 min. After centrifuging the mixture at 13,000 rpm for 10 min, the pink-colored supernatant was collected and absorbance was measured at 532 nm using a Spectra Max M2 plate reader (Molecular Device, Sunnyvale, CA, USA).
Measurement of Glutathione
DTNB (5,5′-dithiobis 2-nitrobenzoic acid) was used to ascertain glutathione (GSH) level as described previously (Kalani et al., 2014b) . Briefly, homogenized cortical and hippocampus samples were treated with an equal volume of 5 % TCA and centrifuged at 3,000 rpm for 10 min. The supernatant (0.05 ml) was transferred to another tube containing 0.1 ml phosphate buffer (pH 8.4), DTNB, and 0.05 ml double distilled water. The content of the tube were mixed and absorbance was recorded at 412 nm using a Spectra Max M2 plate reader (Molecular Device).
SDS-PAGE and Western Blotting
Protein from brain sample was extracted in radioimmumoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 7.4; 1% NP-40; 0.25% Na-deoxycholate, 150 mM NaCl; 1 mM EDTA; 1 μg/ml each of aprotinin, leupeptin, pepstatin; 1 mM Na 3 VO 4 ; 1 mM NaF) containing protease inhibitors (1 mM phenylmethanesulfonyl fluoride and 1 μg complete protease inhibitors, Sigma). Supernatant was collected after centrifuging the brain homogenate at 12,000 × g for 15 min in cold condition. Protein estimation of the samples was performed using Bradford reagent (BioRad, CA, USA) against a bovine serum albumin standard (BSA) (Kalani et al., 2014b) . Equal quantity (25 μg) of protein samples from different experimental groups were run on SDS-PAGE. The separated proteins on the gel were transferred to polyvinyl difluoride (PVDF) membrane by using an electrotransfer apparatus (Bio-Rad). The transfer was run overnight at 120 mA in cold condition. The membrane was checked with ponceau dye (BioRad) to ensure the transfer and processed for blocking with 5% non-fat dry milk in PBS. After that, membrane was incubated overnight in primary antibody (GFAP, dilution 1:500) at 4°C. After washing unbound antibody, membrane was incubated with appropriate secondary antibody (Santa cruz, dilution 1:5000) at room temperature for 60 min and developed with chemiluminescent developing reagent (Biorad). The membrane was stripped and re-probed with anti-GAPDH antibody (Millipore, dilution 1:1000), which was used as a loading control. The images were acquired in a gel documentation system (BioRad) and densitometry analysis was performed using the image lab software.
Quantitative gene expression analysis
Total RNA from experimental brain tissues were isolated using TRIzol® reagent (Invitrogen, Grand Island, NY, USA) as per manufacture's protocol. The pure quality and quantity of RNA was confirmed by using nanodrop-1000 (Thermo Scientific, Waltham, MA, USA). Complimentary DNA (cDNA) was prepared from RNA using manufacture's protocol (ImProm-II ™ , Invitrogen, USA). CDNA samples were amplified for the given genes by genespecific primers (TNF-α, NMDA-R1, NR2A, NR2B and Rn18s or GAPDH) using Stratagene Mx3000p (Agilent Technologies, Santa Clara, CA, USA). After baseline and threshold adjustments, CT (cycle threshold) values were determined. The transcript levels of given genes were normalized with Rn18s/GAPDH and the data was expressed in fold expression.
Immunohistochemistry
For a set of experiments, mice were infused with tetramethylrhodamine β-isothiocyanate (TRITC) -conjugated lycopersicon esculentum agglutinin (LEA) tomato lectin (Vector Laboratories, Burlingame, CA, USA) through carotid artery cannulation. LEA binds to vascular endothelial cells. Animals were perfused transcardially with PBS under anesthetic overdose. Cranium was carefully opened and the brain was gently removed. Frozen brain blocks (prepared with OCT media, Triangle Biomedical Sciences, Durham, NC, USA) were prepared and 15μm coronal brain sections were cut using a cryostat (Leica CM, USA).
For other sets of experiments, frozen blocks were cut into 25 μm sections using a cryostat. The sections were post-fixed after removing mounting matrix and then blocked with blocking solution (0.1% Triton X-100 TBS (TBS-T), 0.5% BSA, and 10% normal donkey serum) for 1 h at room temperature. Sections were incubated overnight in primary antibody for ICAM (Santa cruz, 1: 100), GFAP (Neuromab, 1: 100), NeuN (Abcam, 1:200), VEcadherin (Santa cruz, 1: 100), claudin-5 (Santa cruz, 1:200), occludin (Santa cruz, 1: 100) at 4°C. After washing the unbound antibody in TBS, the sections were further incubated with appropriate fluorescence secondary antibodies for 60 min at room temperature. After that, sections were incubated with DAPI (1:10,000) for 10 min at room temperature and mounted with anti-fade mounting media. Images were acquired using a laser scanning confocal microscope (FluoView 1000; Olympus, PA, USA) and the data was analyzed with image analysis software (Image-Pro Plus; Media Cybernetics, Rockville, MD, USA).
Statistical Analysis
All values are expressed as mean ± SEM. Interaction between groups was determined by one -way analysis of variance (ANOVA) test followed by appropriate post-hoc test. P value equal to or less than 0.05 was considered statistically significant.
RESULTS

Isolation of MESC-exo and characterization of MESC-exo cur
Based on the Brownian motions, the size of the MESC-exo was determined as 118 nm by NTA (Figure-1A, 1B, 1C) . The integrity of MESC-exo and MESC-exo cur (curcumin loaded in MESC-exo) was determined by Western blotting with TSG101 antibody and AchE activity. Western blot analysis determined specific presence of TSG101 band in MESCexo cur and MESC-exo preparations (Figure-1D ). The two preparations (MESC-exo cur and MESC-exo) also showed greater AchE activity as compared to control (culture condition media supernatant deprived of exosomes; 1, 40,000 × g supernatant) (Figure-1E ).
MESC-exo cur treatment reduced post ischemic events in Ischemia injured IR mice
We determined whether intranasal delivery targets MESC-exo cur units to the brain using IHC analysis of the brain coronal sections. Mice administered intra-nasally with fluorescent MESC-exo cur showed presence of MESC-exo cur in different brain cellular compartments; astrocytes (GFAP), neurons (NeuN), and vessels (LEA) ( Figure-2A) .
To determine the therapeutic efficacy of MESC-exo cur against IR-injury, we determined neurological score, lesion volume, and cerebral edema in IR-injured mice. As compared to IR mice, IR+ MESC-exo cur mice showed improvement in neurological scores at 3 rd and 7 th day after treatment (Figure-2B) . Similarly, MESC-exo cur administered IR-mice showed significant reduction in lesion volume, and brain water content as compared to untreated IRmice ( Figure-2C, 2D ). No considerable signs of neurological deficits, brain water content and injured volume were detected in sham and sham+ MESC-exo cur mice (Figure-2B, 2C,   2D ).
MESC-exo cur treatment reduced inflammation
Since inflammation mediates myriads of pathological events following an ischemic insult, we determined whether MESC-exo cur can reduce inflammation which further decreases reactive oxygen speciesn. IR-injured mice showed increased level of ROS, which got significantly decreased with MESC-exo cur treatment (Figure-3A) . Through real-time PCR analysis, we determined the transcript expression of an important pro-inflammatory cytokine, TNF-α, in different experimental mice groups. IR mice showed high TNF-α mRNA levels which got significantly reduced in IR+ MESC-exo cur mice (Figure-3B ). Considerable change in TNF-α mRNA level was not observed in sham+ MESC-exo cur mice, as compared to sham (Figure-3B ). As pro-inflammatory cytokines mediate molecular pathways for the inductions of NMDARs, we determined the beneficiary effects of MESCexo cur that could help reducing NMDARs. IR mice showed increased NR1 mRNA expression, and decreased NR2A and NR2B mRNA expressions. Treatment of MESC-exo cur significantly downregulated NR1 mRNA level in IR mice, however; no changes in NR2A and NR2B mRNA levels were observed in IR+ MESC-exo cur mice (Figure-3C) . Alongside, no changes in different NMDARs levels were found in sham+ MESC-exo cur mice as compared to sham (Figure-3C ). IR mice also showed high malondialdehyde(MDA) and reduced glutathione (GSH) levels in cerebral cortex and hippocampus regions, as compared to sham group. Treatment of MESC-exo cur reduced MDA and improved GSH level in the two brain regions of IR mice (table-1)
MESC-exo cur treatment normalized astrocytes and neuronal expression
Ischemic brain pathology mediates through astrogliosis that can further affect neuronal functions. In this regard, we determined the therapeutic effects of MESC-exo cur in normalizing astrogliosis and saving neurons. IHC analysis of IR mice brain showed induced Kalani et reduced GFAP to a considerable extent in IR-injured mice (Figure-4D, 4E ).
MESC-exo cur treatment mitigated vascular ICAM and endothelial junction protein expressions
We next determined the beneficiary effects of MESC-exo cur in reducing vascular inflammation (ICAM) and improving endothelial vascular junction protein (VE-cadherin). IHC analysis showed significant increase in ICAM levels and reduction in VE-cadherin level in brain vessels of IR mice ( Figure-5A , 5B). As compared to IR mice, IR+ MESC-exo cur mice showed notable reduction in ICAM and improvement in VE-cadherin levels in brain vessels ( Figure-5A , 5B). However, no change in ICAM and VE-cadherin was observed in sham+ MESC-exo cur mice as compared to sham ( Figure-5A , 5B).
MESC-exo cur treatment reduced tight junction proteins loss
The breakdown of vascular junction proteins can intensify the stroke intensity, therefore; we determined the expressions of vascular tight junction proteins, claudin-5 and occludin. IR mice vessels showed reduced expressions of claudin-5 and occludin which were considerably improved after treating IR mice with MESC-exo cur . Sham and sham+ MESCexo cur mice groups did not show any considerable changes in claudin-5 and occludin expressions.
Discussion
In the current report, we determined the therapeutic potentials of curcumin-loaded embryonic stem cell exosomes (MESC-exo cur ) in neurovascular restoration following IRinjury in mice. Our results indicate that MESC-exo cur reduced neurological score, infarct volume, edema, inflammation, astrogliosis, and NMDAR1 expression following IR-injury in mice. In addition, treatment of MESC-exo cur restored NeuN positive neurons, reduced vascular inflammation and alleviated tight and adherent junctions following IR-injury in mice.
In MESC-exo cur units, there were two therapeutic components: 1, embryonic stem cell derived-exosomes that contain enormous paracrine factors of stem cells; and 2, curcumin, a potent therapeutic molecule. The ability of exosome and curcumin to cross BBB also increases their chance to use as cerebral therapies (Kalani et al., 2014c; Kalani et al., 2014d; Kalani and Tyagi, 2015; Mishra and Palanivelu, 2008) . Recently, stem cell exosomes have been shown therapeutic potentials following stroke (Doeppner et al., 2015; Khan et al., 2015; Xin et al., 2013) . Curcumin possesses a potent anti-inflammatory and anti-oxidative properties and its role in ischemic injury has been largely studied (Dai et al., 2015; Ji et al., 2014; Li et al., 2015; Thiyagarajan and Sharma, 2004) . Low bioavailability due to poor absorption, rapid systemic elimination and quick metabolism limit therapeutic efficacy of curcumin to a significant extent (Kalani et al., 2014c) . Exosomes have been found potential sources that can naturally carry and deliver curcumin (Fan et al., 2014) . Curcumin loaded on exosomes was found to be more soluble, stable and bioavailable and thus showed enhance anti-inflammatory activity against lipopolysaccharide induced septic shock mouse model (Fan et al., 2014) . In agreement, we also found more solubility and stability of curcumin in our exosomal nano-formulations MESC-exo cur (data not shown). In addition, a recent study determined 10-40% drug (chemopreventive, chemotherapeutic, and curcumin) load in exosomes derived from bovine milk (Munagala et al., 2015) . Using AchE and western blotting analysis, with exosome specific antibody TSG101, we found that MESC-exo cur units showed AchE activity and specific TSG101 band similar to MESC-exo. These results clearly indicate that the integrity of exosomes was preserved while loading curcumin to exosomes. We used intranasal delivery of MESC-exo cur that showed successful cerebral delivery and neurovascular restorations following an IR-injury. Earlier, intranasal deliveries of curcumin and catalase loaded-exosomes were also found to get targeted to the brain and effective against LPS-induced brain inflammation and Parkinson's disease mice models (Haney et al., 2015; Zhuang et al., 2011) . Although the exact route from nasal route to the brain is not cleared, the transport is believed to be mediated through olfactory and trigeminal nerves (Zhuang et al., 2011) . We reported the presence of exosomes to different cellular components of the mouse brain after intranasal administration, for instance; glia, neurons and around vascular endothelial cells, which is in consistent with previous reports (Haney et al., 2015; Zhuang et al., 2011) . The choice of MESC-exo cur administration through intranasal route in IR-injured mice was based on exciting findings of the previous study (Zhuang et al., 2011) . In the later study curcumin-loaded exosomes, administered through intranasal route, were detectable till 12 h in olfactory bulb and repeated administration of exosome loaded curcumin maintained the curcumin concentration at an average of 2.6 ± 0.4 nmol/g of brain tissue (Zhuang et al., 2011) . Wang et al. have also reported that the distribution of curcumin in brain versus blood was found higher through intranasal route as compared to other routes. As compared to untreated IR-injured mice, MESC-exo cur -treated mice showed significant decrease in neurological score starting from 3 rd day of treatment. Notable decrease in cerebral edema and infarct volume was also noticed in MESC-exo cur -treated mice that suggests therapeutic potential of exosomal nanoformulations.
Inflammatory mechanisms are responsible for several brain-associated pathologies and injuries, including IR-injury (Lakhan et al., 2009; Rai et al., 2013) . The injured tissue following IR-injury releases the ROS that triggers the inflammatory cytokine levels. We reported increased ROS and pro-inflammatory cytokine TNF-α levels increased in IR injured brain; however, consistent treatment of MESC-exo cur for 7 days extensively reduced the levels of pro-inflammatory cytokine TNF-α level, and ROS. Potent anti-inflammatory effects of curcumin and its increased bioavailability helped in decreasing IR-induced ROS and inflammation. NMDA receptors (NMDARs), the glutamate receptors, are of major interest as they are involved in synaptogenesis, synaptic plasticity, and neuronal circuitry formation. Overactivity of NMDARs results in excitotoxicity that may activate microglia (Chang et al., 2008) . In addition to presence of NMDARs in neuronal population, a report suggests the presence of NMDARs in development, ischemia and post-ischemic events (Zhou et al., 2010) . The studies on animal subjects clearly indicate the involvement of astrocytic glutamate receptor in glial cell signaling (Schipke et al., 2001; Wong, 2006) . In our study, although we observed alterations in NR1, NR2A and NR2B transcripts following IR-insult in mice; however, only NR1 levels were recovered to a significant extent with the use of MESC-exo cur . This suggests the importance of NR1 in restoring neurological events following IR-injury, as studied earlier (Wang et al., 2013) . Astrogliosis, reactive astrocytes, is a process of abnormal increase of astrocytic population after an injury (Gordon et al., 2007) . Reactive astrocytes can benefit or harm neuronal and non-neuronal system they interact. Though not studied in detail, astrocytes have been found to release TNF-α and other inflammatory cytokine levels after a scratch and ischemic injury (Lau and Yu, 2001) . We determined increased GFAP activity, a marker of reactive astrocytes, as well as increased TNF-α expression in IR-injured brain. In addition, the neuronal marker NeuN immunoreactivity was decreased in ischemic lesion suggesting neuronal loss after IR-injury. The use of MESC-exo cur not only helped in restoration of NeuN positive neurons but also in reducing astrogliosis as determined by decreased GFAP expression in IR-injured mice brains.
In addition to neuro-glial system, the therapeutic role of MESC-exo cur was also studied against IR-injured vascular impairment. ICAM-1, a marker of vascular inflammation, expression increases in the presence of pro-inflammatory cytokines, which is otherwise reported low at the basal level (Huber et al., 2006) . The interaction of induced ICAM-1 with disrupted BBB was studied in atherosclerosis, inflammation, and thrombosis (Corti et al., 2004) . The BBB integrity is critically maintained with endothelial tight and adherens junction proteins (Kalani et al., 2014b; Kalani et al., 2015) . IR-injury decreases endothelial junction proteins which also progresses under enhanced inflammation (Kalani et al., 2015) . Similar to these studies, we also found induced ICAM-1 expression and reduced tight junctions (claudin-5 and occludin) and adherent junction (VE-cadherin). The use of MESCexo cur restored considerable vascular integrity by reducing vascular inflammation and restoring tight and adherens junction proteins. Although the findings of the study are exciting that can help in future powerful therapy development, there are certain limitations of the study. First, the treatment of IR-injured mice was started within an hour of injury which does not clinically implicate the conditions of the stroke patients who sometimes reach to the hospitals after hours of ischemic insult. Second, the lack of additional mice groups treated with curcumin and embryonic stem cells alone to compare the combined MESC-exo cur effects. Third, time points analysis of available curcumin concentrations in the blood and mice brain tissues. Hence, future studies are warranted to overcome the given and other relevant limitations associated with the study.
In conclusion, we designed a combined powerful formulation by combining embryonic stem cell exosomes and curcumin, MESC-exo cur , to treat IR-injury in mice. The study results suggest that the innovative formulation helped in restoration of neuro-glial-vascular losses following IR-injury. Exciting results with the nano-formulation and intranasal delivery of MESC-exo cur provides the hope for future potential and non-invasive therapeutics for stroke.
The hypothesis is presented in pictorial presentation (Figure-7) .
TBS-T
Tris-buffered saline with Triton X-100
TNF-α Tumor necrosis factor
TSG101
Tumor susceptibility gene101
Highlights
• This is the important study that describes the combined therapeutic potentials of curcumin and embryonic stem cell exosomes.
• Stem cells have rejuvenating properties and curcumin possesses antiinflammatory, anti-lipidemic and neurorestoration properties.
• The combined therapeutic units reduced ischemic injury and restored neuro-vascular unit following ischemia-reperfusion injury in mice. 
